08/09/2017
RICE Publications
RICE Publications 2017
Original Papers
Aisen PS, Cummings J, Jack CR Jr, Morris JC, Sperling R, Frölich L, Jones RW, Dowsett SA, Matthews BR, Raskin J, Scheltens P, Dubois B.
On the path to 2025: understanding the Alzheimer's disease continuum.
Alzheimers Res Ther. 2017 Aug 9;9(1):60. doi: 10.1186/s13195-017-0283-5. Review.
Gustavsson A, Green C,Jones RW, Förstl H, Simsek D, de Reydet de Vulpillieres F, Luthman S, Adlard N, Bhattacharyya S, Wimo A.
Current issues and future research priorities for health economic modelling across the full continuum of Alzheimer's disease.Alzheimers Dement.2017 Mar;13(3):312-32.
Guzmán A, Robinson L, Rochester L, James IA, Hughes JC.
A process evaluation of a Psychomotor Dance Therapy Intervention (DANCIN) for behavior change in dementia: attitudes and beliefs of participating residents and staff. Int Psychogeriatr. 2017 Feb;29(2):313-322. Epub 2016 Nov 7.
Hughes JC.
Rational Suicide in the Elderly: Clinical, Ethical, and Sociocultural Aspects.
Br J Psychiatry. 2017 Jul;211(1):55. doi: 10.1192/bjp.bp.116.
Hughes JC.
Whole sight: clinical and research priorities in old age psychiatry. Lancet Psychiatry. 2017 Feb;4(2):94-95.
Hughes JC, Ingram TA, Jarvis A, Denton E, Lampshire Z, Wernham C.
Consent for the diagnosis of preclinical dementia states: A review. Maturitas. 2017 Apr; 98:30-34. Epub 2017 Jan 19.
Jones RW, · Lebrec J,· Kahle-Wrobleski K, · Dell’Agnello G, · Bruno G, · Vellas B, · Argimon J.M,· Dodel R,· Haro JM, · Wimo A,· Reed C.Disease Progression in Mild Dementia due to Alzheimer Disease in an 18-Month Observational Study (GERAS): The Impact on Costs and Caregiver Outcomes. Dement Geriatr Cogn Disord Extra 2017;7:87-100.
Reed C, Barrett A, Lebrec J, Dodel R, Jones RW, Vellas B, Wimo A, Argimon JM, Bruno G, Haro JM.How useful is the EQ-5D in assessing the impact of caring for people with Alzheimer's disease? Health Qual Life Outcomes. 2017 Jan 21;15(1):16.
Reed C, Happich M, Argimon JM, Haro JM, Wimo A, Bruno G, Dodel R, Jones RW, Vellas B, Belger M.
What Drives Country Differences in Cost of Alzheimer's Disease? An Explanation from Resource Use in the GERAS Study. J Alzheimers Dis. 2017;57(3):797-812.
van der Wardt V, Harrison JK, Welsh T, Conroy S, Gladman J.
Withdrawal of antihypertensive medication: a systematic review.J Hypertens. 2017 May 9. doi: 10.1097/HJH.0000000000001405. [Epub ahead of print]
RICE Publications 2016
Original Papers
Belger M, Haro JM, Reed C, Happich M, Kahle-Wrobleski K, Argimon JM, Bruno G, Dodel R,Jones RW, Vellas B & Wimo A.
How to deal with missing longitudinal data in cost of illness analysis in Alzheimer's disease-suggestions from the GERAS observational study.BMC Med Res Methodol.2016; 16(1), 83.
Cummings J, Aisen PS, DuBois B, Frolich L, Jack CR, Jones RW, Morris JC, Raskin J, Dowsett SA & Scheltens P.
Drug development in Alzheimer's disease: the path to 2025. Alzheimers Res Ther, 2016: 8: 39.
Ozer S, Noonan K, Burke M, Young J, Barber S, Forster A, Jones R.
The validity of the Memory Alteration Test and the Test Your Memorytest for community-based identification of amnestic mild cognitive impairment. Alzheimers Dement. 2016 May 2.[Epub ahead of print]
Reed C, Belger M, Vellas B, Andrews JS, Argimon JM, Bruno G,Jones RW, Wimo A & Haro JM
Identifying factors of activities of daily living important for cost and caregiver outcomes in Alzheimer's disease.Int Psychogeriatr. 2016;28(2):247-59.
RICE Publications 2015
Original Papers
Bocchetta M, Galluzzi S, Kehoe PG, Aguera E, Bernabei R, Bullock R, Ceccaldi M, Dartigues JF, de Mendonça A, Didic M, Eriksdotter M, Félician O, Frölich L, Gertz HJ, Hallikainen M, Hasselbalch SG, Hausner L, Heuser I, Jessen F,Jones RW, Kurz A, Lawlor B, Lleo A, Martinez-Lage P, Mecocci P, Mehrabian S, Monsch A, Nobili F, Nordberg A, Rikkert MO, Orgogozo JM, Pasquier F, Peters O, Salmon E, Sánchez-Castellano C, Santana I, Sarazin M, Traykov L, Tsolaki M, Visser PJ, Wallin ÅK, Wilcock G, Wilkinson D, Wolf H, Yener G, Zekry D, Frisoni GB.
The use of biomarkers for the etiologic diagnosis of MCI in Europe: an EADC survey.Alzheimers Dement. 2015 Feb;11 (2):195-206.e1.
Chouliaras L, Kenis G, Visser PJ, Scheltens P, Tsolaki M, Jones RW, et al. DNMT3A moderates cognitive decline in subjects with mild cognitive impairment: replicated evidence from two mild cognitive impairment cohorts. Epigenomics. 2015;7(4):533-7.
Coley N, Gallini A, Gares V, Gardette V, Andrieu S.(Jones RWcollaborator)
A Longitudinal Study of Transitions Between Informal and Formal Care in Alzheimer Disease Using Multistate Models in the European ICTUS Cohort.J Am Med Dir Assoc. 2015;16(12):1104.e1-7.
Dodel R, Belger M, Reed C, Wimo A, Jones RW, Happich M, et al.
Determinants of societal costs in Alzheimer's disease: GERAS study baseline results. Alzheimers Dement. 2015;11(8):933-45.
Grotz C, Letenneur L, Bonsang E, Amieva H, Meillon C, Quertemont E, et al. .(Jones RWcollaborator)
Retirement age and the age of onset of Alzheimer's disease: results from the ICTUS study. PLoS One. 2015;10(2):e0115056.
Hoffman, P., Clarke, N., Jones, R.W., Noonan, K.A.
Vocabulary relearning in semantic dementia: Positive and negative consequences of increasing variability in the learning experience. Neuropsychologia. 2015 Jan 10. [Epub ahead of print]
Jones RW, Romeo R, Trigg R, Knapp M, Sato A, King D, et al. Dependence in Alzheimer's disease and service use costs, quality of life, and caregiver burden: the DADE study. Alzheimers Dement. 2015;11(3):280-90.
Reed C, Barrett A, Lebrec J, Dodel R, Jones RW, Vellas B, et al.
How Useful are Eq-5d And Zbi In Assessing The Impact of Caring for Alzheimer's Disease Patients? Value Health. 2015;18(7):A760.
Trigg R, Jones RW, Knapp M, King D, Lacey LA.
The relationship between changes in quality of life outcomes and progression of Alzheimer's disease: results from the dependence in AD in England 2 longitudinal study. Int J Geriatr Psychiatry. 2015;30(4):400-8.
Wessels AM, Siemers ER, Yu P, Andersen SW, Holdridge KC, Sims JR,Sundell K, Stern Y, Rentz DM, Dubois B,Jones RW, Cummings J, Aisen PS.
A Combined Measure of Cognition and Function for Clinical Trials: The Integrated Alzheimer's Disease Rating Scale (iADRS).J Prev Alzheimers Dis. 2015;2(4):227-41.
RICE Publications 2014
Original Papers
Bocchetta, M., Galluzzi, S., Kehoe, P.G., Aguera, E., Bernabei, R., Bullock, R., Ceccaldi, M., Dartigues, J.F., de Mendonça, A., Didic, M., Eriksdotter, M., Félician, O., Frölich, L., Gertz, H.J., Hallikainen, M., Hasselbalch, S.G., Hausner, L., Heuser, I., Jessen, F., Jones, R.W., Kurz, A., Lawlor, B., Lleo, A., Martinez-Lage, P., Mecocci, P., Mehrabian, S., Monsch, A., Nobili, F., Nordberg, A., Olde Rikkert, M., Orgogozo, J.M., Pasquier, F., Peters, O., Salmon, E., Sánchez-Castellano, C., Santana, I., Sarazin, M., Traykov, L., Tsolaki, M., Visser, P.J., Wallin, A.K., Wilcock, G., Wilkinson, D., Wolf, H., Yener, G., Zekry, D., Frisoni, G.B.
The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey. Alzheimers Dement. 2014 Aug 20 [Epub ahead of print]
Canevelli, M., Adali, N., Kelaiditi, E., Cantet, C., Ousset, P-J., Cesari, M. Ictus DSA Group [Jones RW member of Ictus study group]
Effects of Gingko biloba supplementation in Alzheimer's disease patients receiving cholinesterase inhibitors: Data from the ICTUS study. Phytomedicine 2014; 21(6): 888-92.
Clare, L., Nelis, S.M., Quinn, C., Martyr, A., Henderson, C., Hindle, J.V., Jones, I.R., Jones, R.W., Knapp, M., Kopelman, M.D., Morris, R.G., Pickett, J.A., Rusted, J.M., Savitch, N.M., Thom, J.M. & Victor, C.R.
Improving the experience of dementia and enhancing active life - living well with dementia: study protocol for the IDEAL study. Health Qual Life Outcomes. 2014; 12(1):164.
Clarke, N. & Jones, R.W.
25 years and counting. The Journal of Dementia Care 2014; 22(3): 14-15.
Gardette, V., Lapeyre-Mestre, M., Piau, A., Gallini, A., Cantet, C., Montastruc, J.L., Vellas, B., Andrieu, S. & Ictus Group. [Jones RW member of Ictus study group] A 2-year prospective cohort study of antidementia drug non-persistency in mild-to-moderate Alzheimer's disease in Europe : predictors of discontinuation and switch in the ICTUS study. CNS Drugs 2014; 28(2):157-70.
Haro, J.M., Kahle-Wrobleski, K., Bruno, G., Belger, M., Dell'Agnello, G., Dodel, R., Jones, R.W., Reed, C.C., Vellas, B., Wimo, A. & Argimon, J.M.
Analysis of burden in caregivers of people with Alzheimer's disease using self-report and supervision hours. J Nutr Health Aging 2014; 18(7): 677-84.
Reed,C., Belger, M., Dell'Agnello,G., Wimo, A., Argimon,J.M. Bruno,G., Dodel,R., Haro,J.M., Jones,R.W. & Vellas,B. Caregiver Burden in Alzheimer's Disease: Differential Associations in Adult-Child and Spousal Caregivers in the GERAS Observational Study. Dementia and Geriatric Cognitive Disorders Extra 2014; (4): 51-64.
Ritchie, C.W., Bajwa, J., Coleman, G., Hope, K., Jones, R.W., Lawton, M., Marven, M. & Passmore, P.
Souvenaid: a new approach to management of early Alzheimer's disease. The Journal of Nutrition, Health & Aging 2014; 18(3): 291-9.
Trigg, R., Jones, R.W., Knapp, M., King, D., Lacey, L.A, (DADE-2 Investigator Groups).
The relationship between changes in quality of life outcomes and progression of Alzheimer's disease: results from the Dependence in AD in England 2 longitudinal study. Int J Geriatr Psychiatry [Epub ahead of print]
Wimo, A., Ballard, C., Brayne, C., Gauthier, S., Handels, R., Jones, R.W., Jonsson, L., Khachaturian, A.S. & Kramberger, M.
Health economic evaluation of treatments for Alzheimer's disease: impact of new diagnostic criteria. Journal of Internal Medicine 2014; 275(3):304-16.
Book Chapter
Jones, R.W.
Preventing Alzheimer's Disease. In: Bairu, M. Weiner, M. W. eds.Global Clinical Trials for Alzheimer's Disease: Design, Implementation, and Standardization. Elsevier Academic Press. 2014. pp 33-46.
RICE Publications 2013
Original Papers
Canevelli, M., Adali, N., Cantet, C., Andrieu, S., Bruno, G., Cesari, M., Vellas, B. & Ictus Dsa Grp [Jones RW member of Ictus study group]
Impact of behavioral subsyndromes on cognitive decline in Alzheimer's disease: data from the ICTUS study. Journal of Neurolog 2013; 260(7):1859-1865.
Clare, L., Bayer, A., Burns, A., Corbett, A., Jones, R., Knapp, M., Kopelman, M., Kudlicka, A., Leroi, I., Oyebode, J., Pool, J., Woods, B. & Whitaker, R.
Goal-oriented cognitive rehabilitation in early-stage dementia: study protocol for a multi-centre single-blind randomised controlled trial (GREAT).Trials;14: 152.
Damian, M., Hausner, L., Jekel, K., Richter, M., Froelich, L., Almkvist, O., Boada, M., Bullock, R., De Deyn, P.P., Frisoni, G.B., Hampel, H., Jones, R.W., Kehoe, P., Lenoir, H., Minthon, L., Olde Rikkert, M.G., Rodriguez, G., Scheltens, P., Soininen, H., Spiru, L., Touchon, J., Tsolaki, M., Vellas, B., Verhey, F.R., Winblad, B., Wahlund, L.O., Wilcock, G. & Visser, P.J.
Single-Domain Amnestic Mild Cognitive Impairment Identified by Cluster Analysis Predicts Alzheimer's Disease in the European Prospective DESCRIPA Study. Dement Geriatr Cogn Disord,2013; 36: 1-19.
Hoffman, P., Jones, R.W. & Lambon Ralph, M.A.
Be concrete to be comprehended: Consistent imageability effects in semantic dementia for nouns, verbs, synonyms and associates. Cortex 2013; 49: 1206-18.
Martinez, C., Jones, R.W. & Rietbrock, S.
Trends in the prevalence of antipsychotic drug use among patients with Alzheimer's disease and other dementias including those treated with antidementia drugs in the community in the UK: a cohort study. BMJ Open; 2013: 3.
Noonan, K.A., Jefferies, E., Garrard, P., Eshan, S. & Lambon Ralph, M.A.
Demonstrating the qualitative differences between semantic aphasia and semantic dementia: a novel exploration of nonverbal semantic processing. Behav Neurol. 2013; 26: 7-20.
Noonan, K.A., Jefferies, E., Visser, M. & Lambon Ralph, M.A., 2013. Going beyond Inferior Prefrontal Involvement in Semantic Control: Evidence for the Additional Contribution of Dorsal Angular Gyrus and Posterior Middle Temporal Cortex. Journal of cognitive neuroscience, 25(11), pp. 1824-50.
Vermeiren, A.P., Bosma, H., Visser, P.J., Zeegers, M.P., Graff, C., Ewers, M., Frisoni, G.B., Frölich, L., Hampel, H., Jones, R.W., Kehoe, P.G., Lenoir, H., Minthon, L., Nobili, F.M., Olde Rikkert, M., Rigaud, A.S., Scheltens, P., Soininen, H., Spiru, L., Tsolaki, M., Wahlund, L.O., Vellas, B., Wilcock, G., Elias-Sonnenschein, L.S. & Verhey, F.R.
The Association Between APOE ε4 and Alzheimer-type Dementia Among Memory Clinic Patients is Confined to those with a Higher Education. The DESCRIPA Study. J Alzheimers Dis 2013; 35: 241-246
Wimo, A., Reed, C.C., Dodel, R., Belger, M., Jones, R.W., Happich, M., Argimon, J.M., Bruno, G., Novick, D., Vellas, B. & Haro, J.M.
The GERAS Study: A Prospective Observational Study of Costs and Resource Use in Community Dwellers with Alzheimer's Disease in Three European Countries - Study Design and Baseline Findings. J Alzheimers Dis. 2013; 36(2): 285-399.
Book Chapters 2013
Jones, R.W.
Pharmacological treatment of dementia. In: Dening,T. & Thomas, A. eds. Textbook of Old Age Psychiatry 2nd Edition.Oxford: Oxford University Press. 2013:Chapter 38, 503-512.
Jones, R.W.
Services for people with mild dementia. In: H. de Waal, C. Lyketsos, D. Ames & J. O'Brien, eds. Designing and Delivering Dementia Services. Wiley-Blackwell 2013; Section 2.5 Service models p 60-72.
RICE Publications 2012
Original Papers
Francis, P.T., Parsons, C.G. & Jones, R.W.
Rationale for combining glutamatergic and cholinergic approaches in the symptomatic treatment of Alzheimer's disease. Expert Rev Neurother. 2012; 12: 1351-65.
Hoffman, P., Jones, R.W. & Lambon Ralph, M.A.,
The degraded concept representation system in semantic dementia: damage to pan-modal hub, then visual spoke. Brain2012; 135: 3770-80.
Hoffman P, Jefferies E, Ehsan S, Jones RW, Lambon Ralph MA.
How does linguistic knowledge contribute to short-term memory? Contrasting effects of impaired semantic knowledge and executive control. Aphasiology 2012; 26 (3-4):383-403.
Hoffman P, Jones RW & Lambon Ralph MA.
Be concrete to be comprehended: Consistent imageability effects in semantic dementia for nouns, verbs, synonyms and associates. Cortex 2012; 49(5): 1206-1218. (co-author)
Howard, R., McShane, R., Lindesay, J., Ritchie, C., Baldwin, A., Barber, R., Burns, A., Dening, T., Findlay, D., Holmes, C., Hughes, A., Jacoby, R., Jones, R., Jones, R., McKeith, I., Macharouthu, A., O'Brien, J., Passmore, P., Sheehan, B., Juszczak, E., Katona, C., Hills, R., Knapp, M., Ballard, C., Brown, R., Banerjee, S., Onions, C., Griffin, M., Adams, J., Gray, R., Johnson, T., Bentham, P. & Phillips, P.
Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease. New England Journal of Medicine,2012; 366: 893-903.
Noonan KA, Pryer LR, Jones RW, Burns AS, Lambon Ralph MA
A direct comparison of errorless and errorful therapy for object name relearning in Alzheimer’s disease. Neuropsychological Rehabilitation 2012; 22(2): 215-234.
Trigg R, Watts S, Jones R, Tod A, Elliman R.
Self-reported quality of life ratings of people with dementia: the role of attitudes to aging.
International Psychogeriatrics 2012; 24:7 1085-1093.
Vellas, B., Hausner, L., Frölich, L., Cantet, C., Gardette, V., Reynish, E., Gillette, S., Ag Era-Morales, E., Auriacombe, S., Boada-Rovira, M., Bullock, R., Byrne, J., Cherubini, A., Eriksdotter-J Nhagen, M., Frisoni, G., Hasselbalch, S., Jones, R., Martinez-Lage, P., Rikkert, M., Tsolaki, M., Ousset, P.J., Pasquier, F., Ribera-Casado, J.M., Rigaud, A.S., Robert, P., Rodriguez, G., Salmon, E., A, S., Scheltens, P., Schneider, A., Spiru, L., Touchon, J., Zekry, D., Winblad, B. & Andrieu, S.
Progression of Alzheimer disease in Europe: Data from the European ICTUS study. Curr Alzheimer Res. 2012; 9 (8): 902-912.
2012 – CONFERENCE ABSTRACTS
Jones, R.W., Lacey, L., Knapp, M., Romeo, R., Sato, A., Niecko, T., Trigg, R. (Dade Investigator Group)
Patient dependence and clinical measures of cognitive impairment, functional disability and behaviour in Alzheimer's disease: results from dependence in AD in England (DADE) study. European Journal of Neurology 2012;19: S1
Knapp, M., Romeo, R., Sato, A., Jones, R.W., Lacey, L.A. (Dade Investigator Group).
Relationship between healthcare, social care costs, dependence on others as illness progresses in Alzheimer's disease (AD): results from dependence in AD in England (DADE) study. European Journal of Neurology2012; 19:S1
Lacey, L., Jones, R.W.,Trigg, R., Niecko, T. (Dade Study Group)
Caregiver burden as illness progresses in Alzheimer's disease (AD): association with patient dependence and other factors: results from dependence in AD in England (DADE) study. European Journal of Neurology2012; 19:S1
Lyketsos C, Tariot P, Jones R and Kinney G, Abushakra S.
What constitutes evidence of target engagement in AD trials? ELND005 CNS pharmacokinetics, biomarker and safety profile.
Neurobiology of Aging 2012; 33: S1-S30.
Trigg, R., Jones, R.W., Lacey, L., Niecko, T. (Dade Investigator Group)
Relationship between self-assessed and proxy-assessed quality of life (QoL) and dependence in Alzheimer's disease (AD): results from dependence in AD in England (DADE) study. European Journal of Neurology,2012 19: S1
2011 – ORIGINAL PAPER
Howard R, Phillips P, Johnson T,O'Brien J, Sheehan B, Lindesay J, Bentham P, Burns A, Ballard C, Holmes C, McKeith I, Barber R, Dening T, Ritchie C, Jones R, Baldwin A, Passmore P, Findlay D, Hughes A, Macharouthu A, Banerjee S, Knapp M, Brown R, Jacoby R, Adams J, Griffin M and Gray R.Determining the minimum clinically important differences for outcomes in the DOMINO trial. Int J Geriatr Psychiatr 2011;26(8): 812-817.
Norberg J, Graff C, Almkvist O, Ewers M, Frisoni GB, Frölich L, Hampel H, Jones RW, Kehoe, PG, Lenoir H, Minthon L, Nobili F, Olde Rikkert M, Rigaud AS, Scheltens P, Soininen H, Spiru L, Tsolaki M, Wahlund LO, Vellas B, Wilcock G, Elias-Sonnenschein LS, Verhey FR, Visser PJ.
Regional Differences in Effects of APOE ε4 on Cognitive Impairment in Non-Demented Subjects. Dement Geriatr Cogn Disord 2011; 32(2): 135-142
Waldemar G, Gauthier S, Jones R, Wilkinson D, Cummings J, Lopez O, Zhang R, Xu Y, Sun Y, Knox S, Richardson S, Mackell J.
Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease. International Journal of Geriatric Psychiatry 2011; 26(2): 150-157.
Jones R, Wilkinson D, Lopez O, Cummings J, Waldemar G, Zhang R, Mackell J, Gauthier S.
Collaborative research between academia and industry using a large clinical trial database: a case study in Alzheimer's disease. Trials 2011; 12: 233.
2011 – CONFERENCE ABSTRACT
Jones RW
Are extensive examinations necessary in the diagnosis of Alzheimer’s Disease? The case against! European Journal of Neurology. 2011; 18:18
2011 - REVIEW
Jones RW
Drug treatment for people with dementia.
Clinical Medicine 2011; 11(1): 67-71
2010 – ORIGINAL PAPER
Cummings J, Jones R, Wilkinson D, Lopez O, Gauthier S, Waldemar G, Zhang R, Xu Y, Sun Y, Richardson S, Mackell J.
Effect of Donepezil on Cognition in Severe Alzheimer's Disease: A Pooled Data Analysis.
Journal of Alzheimer’s Disease 2010; 21(3):843-851
Emre M, Tsolaki M, Bonuccelli U, Destee A, Tolosa E, Kutzelnigg A, Ceballos-Baumann A, Zdravkovic S, Bladstrom A, Jones RW: Study Investigators
Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2010; 9(10):969-77
Feldman H, Doody RS, Kivipelto M, Sparks DL, D.D. Waters DD, Jones RW, Schwam R,
Hey-Hadavi J, DeMicco DA, Breazna
Randomized controlled trial of atorvastatin in mild to moderate Alzheimer’s Disease. Neurology 2010;74: 956-964
Frank L, Howard K, Jones RW, Lacey, L, Leibman C, Pharm D, Lleo A, Mannix S, Mucha L, McLaughlin T, Zarit S
A Qualitative Assessment of the Concept of Dependence in Alzheimer’s Disease
American Journal of Alzheimer's Disease and Other Dementias2010; 25(3): 239-247
Gauthier S, Lopez OL, Waldemar G, Jones RW, Cummings J, Zhang R, Schindler R, Schwam E
Effects of donepezil on activities of daily living: integrated analysis of patient data from studies in mild, moderate and severe Alzheimer’s disease.
International Psychogeriatrics 2010;22(6): 973-983
Gustavsson A, Jonsson L, Rapp T, Reynish E, Ousset PJ, Andrieu S, Cantet C, Winblad B, Vellas B, Wimo A, Ictus Study Group,(Jones R W: one of the study investigators).
Differences in resource use and costs of dementia care between European countries: baseline data from the ICTUS study
J Nutr Health Aging 2010; 14(8): 648-54
Howard R, Phillips P, Johnson T, O'Brien J, Sheehan B, Lindesay J, Bentham P, Burns A, Ballard C, Holmes C, McKeith I, Barber R, Dening T, Ritchie C, Jones R, Baldwin A, Passmore P, Findlay D, Hughes A, Macharouthu A, Banerjee S, Jones R, Knapp M, Brown RG, Jacoby R, Adams J, Griffin M, Gray R.
Determining the minimum clinically important differences for outcomes in the DOMINO trial.
Int J Geriatr Psychiatry 2010 Sep 16 (E Pub)
Jones RW
Dimebon disappointment
Alzheimer’s Research Therapy 2010 2(25)(E pub)
Jones RW, Andrieu S, Knox S, Mackell J
Physicians and caregivers: ready and waiting for increased participation in clinical research.
The Journal of Nutrition, Health & Aging 2010; 14(7): 563-568
Jones RW, Mackell J, Berthet K, Knox S
Assessing attitudes and behaviours surrounding Alzheimer ’s Disease in Europe: key findings of the important perspectives of Alzheimer’s care and treatment (Impact) survey.
The Journal of Nutrition, Health & Aging 2010; 14(7): 525-530
Lambon Ralph MA, Sage K, Jones RW and Mayberry E.
Coherent concepts are computed in the anterior temporal lobes.
Proc Natl Acad Sci USA 2010; 107(6): 2717-22
Lopez OL, Schwam E, Cummings J, Gauthier S, Jones R, Wilkinson D, Waldemar G, Zhang R, Schindler R
Predicting cognitive decline in Alzheimer’s disease: An integrated analysis.
Alzheimers Dement 2010 6(6): 431-439
Metzler-Baddeley C, Baddeley RJ, Lovell PG, Laffan A, Jones RW
Visual Impairments in Dementia with Lewy Bodies and Posterior Cortical Atrophy. Neurophychology 2010; 24(1):35-48
Metzler-Baddeley C, Jones RW. Brief communication: cognitive rehabilitation of executive functioning in a case of craniopharyngioma. Appl Neuropsychol. 2010 Oct;17(4):299-304.
O’Brien JT, Burns A, on Behalf of the BAP Dementia Consensus Group: Ashley P, Bullock R, Burn D, Holmes C, Iliffe S, Jones R, McKeith I, Passmore P, Purandare N, Ritchie CW, Skoog I, Thomas A, Wilcock G, Wilkinson D.
Clinical practice with anti-dementia drugs: a revised (second) consensus statementfrom the British Associationfor Psychopharmacology. Journal of Psychopharmacology 2010; 0(0):1-23
Waldemar G, Gauthier S, Jones R, Wilkinson D, Cummings J, Lopez O, Zhang R, Xu Y, Sun Y, Knox S, Richardson S, Mackell J.
Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease.
Int J Geriatr Psychiatry. 2010 Jul 2. [Epub ahead of print]
2010 – REVIEW ARTICLE
Jones RW
A review comparing the safety and tolerability of memantine with the acetylcholinesterase inhibitors.
International Journal of Geriatric Psychiatry2010;25(6):547-553
2010 – BOOK REVIEW
Jones, RW
Clinical Trials in Psychiatry, 2nd edition
International Journal of Geriatric Psychiatry 2010;25(5): 545-545